The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
Conditions: Esophageal Cancer; Intensity-modulated Radiation Therapy; Concurrent Chemoradiotherapy; Thrombocytopenia Intervention: Drug: rhTPO Sponsors: JIANYANG WANG; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | China Health | Esophagus Cancer | Hospitals | Intensity-Modulated Radiation Therapy | Research | Thrombocytopenia